This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
moving-average-crossover: Archive
Strength Seen in American Water Works (AWK): Can Its 6.8% Jump Turn into More Strength?
by Zacks Equity Research
American Water Works (AWK) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
AWKPositive Net Change AWRPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Toll Brothers (TOL) Soars 3.6%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Toll Brothers (TOL) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
TOLPositive Net Change TPHPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
LegalZoom (LZ) Moves 6.8% Higher: Will This Strength Last?
by Zacks Equity Research
LegalZoom (LZ) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
LZPositive Net Change GWWPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in HubSpot (HUBS): Can Its 4.4% Jump Turn into More Strength?
by Zacks Equity Research
HubSpot (HUBS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
HUBSPositive Net Change CHGGPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Portillo's Inc. (PTLO) Soars 7.2%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Portillo's Inc. (PTLO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
PTLOPositive Net Change DRIPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
EverQuote (EVER) Moves 18.9% Higher: Will This Strength Last?
by Zacks Equity Research
EverQuote (EVER) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
EVERPositive Net Change HGPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Vor Biopharma Inc. (VOR)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
VORNo Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
MediWound (MDWD) Surges 8.5%: Is This an Indication of Further Gains?
by Zacks Equity Research
MediWound (MDWD) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
MDWDPositive Net Change NKTRNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Dana (DAN) Stock Jumps 14.9%: Will It Continue to Soar?
by Zacks Equity Research
Dana (DAN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
DANPositive Net Change CTOSPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Twilio (TWLO): Can Its 20.1% Jump Turn into More Strength?
by Zacks Equity Research
Twilio (TWLO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
TWLOPositive Net Change RGTIPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Theravance Bio (TBPH) Soars 8.3%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Theravance Bio (TBPH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
TBPHPositive Net Change ECORPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Humana (HUM) Soars 3.1%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Humana (HUM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
HUMPositive Net Change CIPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Adidas AG (ADDYY) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
ADDYYPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Root, Inc. (ROOT) Just Overtook the 50-Day Moving Average
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 50-Day simple moving average?
ROOTPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
TripAdvisor (TRIP) Soars 13.9%: Is Further Upside Left in the Stock?
by Zacks Equity Research
TripAdvisor (TRIP) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
TRIPPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
TKO Group (TKO) Soars 6.3%: Is Further Upside Left in the Stock?
by Zacks Equity Research
TKO Group (TKO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
TKOPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Strength Seen in Eton Pharmaceuticals (ETON): Can Its 10.8% Jump Turn into More Strength?
by Zacks Equity Research
Eton Pharmaceuticals (ETON) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
ETONPositive Net Change LEGNPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Guidewire Software (GWRE) Surges 11.5%: Is This an Indication of Further Gains?
by Zacks Equity Research
Guidewire Software (GWRE) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
GWREPositive Net Change PLUSPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
FTAI Aviation (FTAI) Moves 9.8% Higher: Will This Strength Last?
by Zacks Equity Research
FTAI Aviation (FTAI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
FTAIPositive Net Change KTOSPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Recursion Pharmaceuticals (RXRX) Moves 8.9% Higher: Will This Strength Last?
by Zacks Equity Research
Recursion Pharmaceuticals (RXRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
RXRXPositive Net Change ENTAPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Verve Therapeutics (VERV) Moves 18.7% Higher: Will This Strength Last?
by Zacks Equity Research
Verve Therapeutics (VERV) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
KPTIPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
CRISPR Therapeutics (CRSP) Moves 6.5% Higher: Will This Strength Last?
by Zacks Equity Research
CRISPR Therapeutics (CRSP) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
CRSPPositive Net Change TARSPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in RadNet (RDNT): Can Its 5.9% Jump Turn into More Strength?
by Zacks Equity Research
RadNet (RDNT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
RDNTPositive Net Change ASTHPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Solaris Energy Infrastructure, Inc. (SEI) Soars 9.8%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Solaris Energy Infrastructure, Inc. (SEI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
SEIPositive Net Change NOVPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Celestica (CLS) Soars 4.4%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Celestica (CLS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
CLSPositive Net Change SANMPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today